arrow
J

Jostein Starrfelt

University of Oslo
H指数:20
被引数:1,466

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Looking beyond Popper: how philosophy can be relevant to ecology
2024-12-100
OAAI
COVID-19 Vaccine Effectiveness Among Adolescents
2024-01-103
PRE
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023

≥ 65岁人群新型冠状病毒肺炎住院的相对疫苗有效性: 欧洲VEBIS网络的结果,2021年10月2023年7月

2024-01-041
OAAI
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022

2021年10月2022年11月,在六个欧洲国家使用电子健康登记处监测新型冠状病毒肺炎疫苗对新型冠状病毒肺炎住院和死亡的有效性

2023-11-282
OAAI
A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022
2023-09-075
OAAI
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses

在北欧国家omicron占主导地位期间,针对严重新型冠状病毒肺炎的异源第三剂量疫苗方案的比较有效性: 基于人群的队列分析

2023-07-2416
OAAI
Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort

mRNA加强疫苗接种对Omicron变体引起的轻度,中度和重度新型冠状病毒肺炎的有效性,基于人群,挪威队列

2022-10-1913
OAAI
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021

挪威成年人对SARS-CoV-2感染和住院治疗的年龄和产品依赖性疫苗有效性: 一项2021年7月到11月的国家队列研究

2022-09-0224
OAAI
Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022
2022-07-289
OAAI
Genetic control of variability in subcortical and intracranial volumes
2020-02-119
OAAI